Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) plus chemotherapy improved the prognosis of patients with non-small cell lung cancer (NSCLC); however, reliable prognostic biomarkers are lacking. We explored factors associated with prognosis and developed a predictive model. METHODS: We retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Hao, Huang, Wei-wei, Liu, Yu-jie, Huang, Qin, Zhao, Sheng-min, Li, Ya-lun, Tian, Pan-wen, Li, Wei-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397581/
https://www.ncbi.nlm.nih.gov/pubmed/34458139
http://dx.doi.org/10.3389/fonc.2021.685047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397581/
https://www.ncbi.nlm.nih.gov/pubmed/34458139
http://dx.doi.org/10.3389/fonc.2021.685047

Ejemplares similares